125 related articles for article (PubMed ID: 35899960)
21. TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells.
Wang H; Wang X; Xu L; Zhang J
FEBS Open Bio; 2022 Mar; 12(3):616-626. PubMed ID: 35030298
[TBL] [Abstract][Full Text] [Related]
22. The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma.
Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
Tumour Biol; 2014 May; 35(5):4567-80. PubMed ID: 24399651
[TBL] [Abstract][Full Text] [Related]
23. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo].
Lu J; Jin J
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386
[TBL] [Abstract][Full Text] [Related]
24. Arsenic trioxide preferentially induces nonapoptotic cell deaths as well as actin cytoskeleton rearrangement in the CHO AA8 cell line.
Izdebska M; Klimaszewska-Wiśniewska A; Lewandowski D; Marcin Nowak J; Gagat M; Grzanka A
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1492-500. PubMed ID: 25531713
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
Chiu HW; Ho YS; Wang YJ
J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
[TBL] [Abstract][Full Text] [Related]
26. Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells.
Lunghi P; Costanzo A; Levrero M; Bonati A
Blood; 2004 Jul; 104(2):519-25. PubMed ID: 15031205
[TBL] [Abstract][Full Text] [Related]
27. Expression of cyclin A in A549 cell line after treatment with arsenic trioxide.
Żuryń A; Krajewski A; Litwiniec A; Klimaszewska-Wiśniewska A; Grzanka A
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1259-67. PubMed ID: 26671917
[TBL] [Abstract][Full Text] [Related]
28. NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).
Kerbauy DM; Lesnikov V; Abbasi N; Seal S; Scott B; Deeg HJ
Blood; 2005 Dec; 106(12):3917-25. PubMed ID: 16105982
[TBL] [Abstract][Full Text] [Related]
29. Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5.
Kim YH; Shin EA; Jung JH; Park JE; Koo J; Koo JI; Shim BS; Kim SH
Eur J Pharmacol; 2019 Mar; 847():91-96. PubMed ID: 30689998
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells.
Mohammadi Kian M; Mohammadi S; Tavallaei M; Chahardouli B; Rostami S; Zahedpanah M; Ghavamzadeh A; Nikbakht M
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1127-1134. PubMed ID: 29699374
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide and Erlotinib loaded in RGD-modified nanoliposomes for targeted combination delivery to PC3 and PANC-1 cell lines.
Khosravani F; Mir H; Mirzaei A; Kobarfard F; Bardania H; Hosseini E
Biotechnol Appl Biochem; 2023 Apr; 70(2):811-823. PubMed ID: 36070882
[TBL] [Abstract][Full Text] [Related]
32. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
[TBL] [Abstract][Full Text] [Related]
33. Bcl-2 hijacks the arsenic trioxide resistance in SH-SY5Y cells.
Wang J; Peng X; Yang D; Guo M; Xu X; Yin F; Wang Y; Huang J; Zhan L; Qi Z
J Cell Mol Med; 2022 Jan; 26(2):563-569. PubMed ID: 34910369
[TBL] [Abstract][Full Text] [Related]
34. Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway.
Nasrollahzadeh A; Bashash D; Kabuli M; Zandi Z; Kashani B; Zaghal A; Mousavi SA; Ghaffari SH
Life Sci; 2020 Sep; 257():118060. PubMed ID: 32645343
[TBL] [Abstract][Full Text] [Related]
35. Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.
Wang Y; Wei Y; Zhang H; Shi Y; Li Y; Li R
Med Oncol; 2012 Jun; 29(2):1328-34. PubMed ID: 21308489
[TBL] [Abstract][Full Text] [Related]
36. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Lu J; Jin J; Xu WL
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
[TBL] [Abstract][Full Text] [Related]
37. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
38. ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.
Joe Y; Jeong JH; Yang S; Kang H; Motoyama N; Pandolfi PP; Chung JH; Kim MK
J Biol Chem; 2006 Sep; 281(39):28764-71. PubMed ID: 16891316
[TBL] [Abstract][Full Text] [Related]
39. Apoptotic Effect of Galbanic Acid via Activation of Caspases and Inhibition of Mcl-1 in H460 Non-Small Lung Carcinoma Cells.
Oh BS; Shin EA; Jung JH; Jung DB; Kim B; Shim BS; Yazdi MC; Iranshahi M; Kim SH
Phytother Res; 2015 Jun; 29(6):844-9. PubMed ID: 25753585
[TBL] [Abstract][Full Text] [Related]
40. Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines.
Hanafi-Bojd MY; Iranshahi M; Mosaffa F; Tehrani SO; Kalalinia F; Behravan J
Planta Med; 2011 Sep; 77(14):1590-3. PubMed ID: 21484672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
